Use of formaldehyde heavy crosslinking in cut&tag library construction

Through the combination of formaldehyde re-crosslinking and CUT&Tag technology, the weak signal and high background problems of CUT&Tag technology in detecting dynamic DNA-binding proteins are solved, and efficient nucleic acid library construction and sequencing signal-to-noise ratio improvement is achieved, which is suitable for a wide range of proteins -DNA interaction exploration.

WO2024240259A1PCT designated stage expired Publication Date: 2024-11-28NOVOPROTEIN SCI (SHANGHAI) INC +1
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/095287
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-24
Filing Date
2024-05-24
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

When CUT&Tag technology detects the interaction of dynamic DNA-binding proteins, the light crosslinking method is difficult to truly reflect the sample situation. The binding site signal strength is weak and the background is high, making it difficult to be suitable for the exploration of most protein-DNA interactions.

Method used

Fixed cells by formaldehyde re-crosslinking and combined with permeabilization treatment by CUT&Tag technology, a nucleic acid library is constructed. After formaldehyde re-crosslinking, cell permeabilization is carried out to improve cell permeability so that antibodies and enzymes can enter, thus achieving more Efficient fragmentation reactions and library yields.

Benefits of technology

It significantly improves library yield, improves sequencing signal-to-noise ratio, is suitable for exploring weak protein-DNA interactions, reduces cell demand, simplifies the operation process, and takes into account the fixation effect of ChIP experiments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PCTCN2024095287-FTAPPB-I100001
    Figure PCTCN2024095287-FTAPPB-I100001
  • Figure PCTCN2024095287-FTAPPB-I100002
    Figure PCTCN2024095287-FTAPPB-I100002
  • Figure PCTCN2024095287-FTAPPB-I100003
    Figure PCTCN2024095287-FTAPPB-I100003
Patent Text Reader

Abstract

Provided are a method for formaldehyde heavy crosslinking in CUT&Tag library construction and the use thereof. The method involves low cell demands, a high signal-to-noise ratio and relatively simple operation, and achieves the advantages of formaldehyde heavy crosslinking to immobilize cells in ChIP experiments. The method has remarkable advantages in exploring protein-DNA weak interaction.
Need to check novelty before this filing date? Find Prior Art

Description

Application of formaldehyde cross-linking in CUT&Tag technology library construction Technical Field

[0001] The present invention belongs to the field of biotechnology and specifically relates to the application of formaldehyde cross-linking in library construction using the CUT&Tag technology. Background Art

[0002] During normal embryonic development, a fertilized egg carrying identical genetic material differentiates into cells of varying morphologies, ultimately forming a complete organism with distinct tissues and organs. Studies have shown that this differentiation, which does not involve changes in genetic material, is achieved through epigenetic regulation. Epigenetic regulation typically includes gene regulation and chromatin regulation, processes that are closely related to protein-DNA interactions. Disruption of epigenetically controlled gene expression patterns can lead to various diseases, including autoimmune diseases and cancer. Therefore, studying protein-DNA interactions is crucial for understanding the occurrence of disease.

[0003] Currently, the main methods for studying protein-DNA interactions include chromatin immunoprecipitation (ChIP), CUT&RUN, and CUT&Tag (Cleavage Under Targets and Tagmentation) techniques. CUT&Tag technology uses cells or cell nuclei for experiments, eliminating the need for cross-linking and fixing cells (or using light cross-linking with 0.1-0.2% formaldehyde for 2-3 minutes). Targeted disruption is achieved through protein A / protein G-Tn5 transposase. It requires a small number of cells (10,000-100,000 cells), is quick to perform (8-10 hours), has low background noise, and is simple to use.

[0004] However, in extensive practice, researchers have discovered that CUT&Tag technology has limitations. For the detection of interactions between DNA-binding proteins, which bind dynamically to DNA, the non-crosslinking or lightly crosslinked (0.1% to 0.2% formaldehyde) methods used in CUT&Tag technology are difficult to truly reflect the objective conditions of experimental samples. Furthermore, there are also issues with weak signal intensity at binding sites and high background.

[0005] In summary, CUT&Tag technology faces enormous challenges. How to make CUT&Tag applicable to most protein-DNA interactions while maintaining the simplicity and speed of CUT&Tag technology is an urgent problem to be solved.

[0006] Summary of the Invention

[0007] The purpose of the present invention is to provide an application of formaldehyde cross-linking in CUT&Tag technology library construction.

[0008] The present invention also aims to provide a library construction method for target protein immobilization and DNA binding pattern identification.

[0009] The present invention also aims to provide a library construction method for identifying DNA binding patterns of DNA binding proteins that have weak DNA binding affinity or highly dynamic DNA binding.

[0010] In a first aspect of the present invention, a method for constructing a nucleic acid library is provided, comprising:

[0011] (S1) providing a cell sample;

[0012] (S2) immobilizing the cell sample with a crosslinker solution having a final concentration of C1 (v / v) for a time period of t1 (min), where the immobilization integral I1 = C1 * t1, and I1 ≥ 2.5, to obtain a non-permeabilized cell sample;

[0013] (S3) permeabilizing the non-permeabilized cell sample to obtain a permeabilized cell sample;

[0014] (S4) washing the permeabilized cell sample to obtain a washed cell mixture;

[0015] (S5) mixing the cell mixture with pretreated magnetic beads to obtain a cell-magnetic bead complex;

[0016] (S6) treating the cell-magnetic bead conjugate with a primary antibody to obtain a primary antibody-cell-magnetic bead complex;

[0017] (S7) treating the primary antibody-cell-magnetic bead complex with a secondary antibody to obtain a secondary antibody-primary antibody-cell-magnetic bead complex;

[0018] (S8) treating the secondary antibody-primary antibody-cell-magnetic bead complex with a transposase to perform a fragmentation reaction to form DNA fragments;

[0019] (S9) terminating the reaction and decrosslinking to obtain a reaction-terminated product; and

[0020] (S10) isolating, purifying, and amplifying the DNA fragments in the reaction termination product to prepare a nucleic acid library.

[0021] In another preferred embodiment, in (S1), the cells include animal cells, preferably mammalian cells, more preferably hamster cells, human cells or mouse cells.

[0022] In another preferred embodiment, in (S1), the cell density in the cell sample is 1×10 3 ~5×10 6 pieces / mL.

[0023] In another preferred embodiment, in (S2), C1 is 0.5% to 5% (v / v); preferably 1% to 3% (v / v).

[0024] In another preferred embodiment, in (S2), t1 is 5 to 60 min, preferably 10 to 20 min.

[0025] In another preferred embodiment, in (S2), I1 is 2.5-300; preferably I1≥10.

[0026] In another preferred embodiment, in (S2), the immobilization treatment is a sufficient immobilization treatment, which means that all or substantially all cells are cross-linked and fixed; wherein "all or substantially all" means that ≥85%; preferably ≥90%; preferably ≥95%; more preferably ≥98%; and optimally ≥99% of the cells are cross-linked and fixed.

[0027] In another preferred embodiment, in (S2), the cross-linking agent includes but is not limited to formaldehyde, EGS, and DSG, preferably formaldehyde.

[0028] In another preferred embodiment, in (S2), the immobilization treatment includes:

[0029] (S2.1) According to 3×10 3 ~3×10 6 Add the corresponding volume of 0.5% to 5% formaldehyde crosslinker solution to the cell sample in (S1) at a cell density of cells / mL and incubate at room temperature for 5 to 60 minutes;

[0030] (S2.2) Terminate the reaction with glycine at a final concentration of 125-1000 mM for 5-15 min.

[0031] In another preferred embodiment, in (S2), the permeabilization buffer comprises PB, Tris, or HEPES buffer.

[0032] In another preferred embodiment, in (S2), the permeabilizing agent is selected from one or more of the following groups: Tween20, SDS, NP40 (or IGEPAL CA-630), Digtonin, CHAPS, sodium deoxycholate, or a combination thereof; preferably Tween20, SDS or NP40 (or IGEPAL CA-630).

[0033] In another preferred embodiment, in (S3), the permeabilization buffer comprises one or more selected from the group consisting of:

[0034] 0.1%-0.5% (v / v), preferably 0.2% (v / v) NP40,

[0035] 0.1%-0.5% (v / v), preferably 0.1% (v / v) SDS,

[0036] 0.1%-0.5% (v / v), preferably 0.1% (v / v) Tween20,

[0037] 0.01%-0.2% (v / v), preferably 0.05% (v / v) Digitonin,

[0038] 0.1%-0.5% (v / v), preferably 0.1% (v / v) TrinonX-100,

[0039] 0.1%-0.5% (v / v), preferably 0.1% (v / v) CHAPS.

[0040] In another preferred embodiment, in (S3), the permeabilization treatment comprises: permeabilizing the immobilized cell sample for t2 time (min) using a permeabilization buffer containing a C2 (v / v) permeabilization agent to obtain a permeabilized cell sample.

[0041] In another preferred embodiment, in (S3), C2 is 0.005% to 5%, preferably 0.01% to 2%.

[0042] In another preferred embodiment, in (S3), t2 is 5 to 60 min.

[0043] In another preferred embodiment, in (S3), the cell density of the cell permeabilization treatment is 3×10 3 ~3×10 6 pieces / mL.

[0044] In another preferred embodiment, in (S3), the permeation treatment temperature is 45 to 68°C.

[0045] In another preferred embodiment, in (S3), the pH value of the permeation buffer is 7.0-7.8; preferably 7.2-7.6.

[0046] In another preferred embodiment, in (S3), the permeabilization buffer contains 100-200 mM NaCl or other salts with equivalent conductivity strength.

[0047] In another preferred embodiment, in (S3), the permeabilization treatment comprises: treating the immobilized cell sample with a permeabilization buffer, and incubating the cell sample in a temperature-controlled apparatus at 55-65° C. for 5-20 min.

[0048] In another preferred embodiment, in (S4), the washing comprises: adding cell washing buffer, incubating for 20 to 50 minutes, and then centrifuging to remove the supernatant.

[0049] In another preferred embodiment, in (S4), the cell washing buffer is a buffer containing 0.01% to 0.1% (v / v) permeabilizing agent.

[0050] In another preferred embodiment, in (S4), the cell washing buffer comprises one or more permeabilizing agents selected from the group consisting of:

[0051] 0.1%-0.5% (v / v), preferably 0.15% (v / v) Tween20,

[0052] 0.1%-0.5% (v / v), preferably 0.15% (v / v) NP40,

[0053] 0.01%-0.2% (v / v), preferably 0.01% (v / v) Digitonin,

[0054] 0.1%-0.5% (v / v), preferably 0.1% (v / v) Triton X-100.

[0055] In another preferred embodiment, in (S5), the magnetic beads are ConA magnetic beads.

[0056] In another preferred embodiment, in (S6), the primary antibody incubation time is 1 to 16 hours.

[0057] In another preferred embodiment, in (S8), the transposase is selected from: pA-Tn5, pG-Tn5, pA-pG-Tn5; preferably pA / G-Tn5 (protein A-Tn5).

[0058] In another preferred embodiment, in (S8), the incubation interruption time of the transposase is 0.5 to 3 hours.

[0059] In another preferred embodiment, in (S9), the terminating the reaction and de-crosslinking comprises: adding a de-crosslinking reagent for incubation.

[0060] In another preferred embodiment, in (S9), the cross-linking removal reagent includes: 2-10 μL 0.5 M EDTA; 1-8 μL 10% SDS; and 0.2-5 μL 20 mg / mL proteinase K.

[0061] In another preferred embodiment, in (S9), the decrosslinking temperature is 50 to 60°C; and the decrosslinking time is 0.5 to 12 hours.

[0062] In a second aspect of the present invention, a kit for constructing a nucleic acid library using CUT&Tag technology is provided, comprising:

[0063] (1) cross-linking agent solution;

[0064] (2) Permeabilization buffer;

[0065] (3) Cell washing buffer;

[0066] (4) fragmentation reaction reagents; and

[0067] (5) Cross-linking reagent.

[0068] In another preferred embodiment, the cross-linking agent includes but is not limited to formaldehyde, EGS, and DSG, preferably formaldehyde.

[0069] In another preferred embodiment, the concentration C1% of the cross-linking agent is 0.5% to 5%, preferably 1% to 3%.

[0070] In another preferred embodiment, the permeabilization buffer comprises PB, Tris, or HEPES buffer.

[0071] In another preferred embodiment, the pH value of the permeabilization buffer is 7.0-7.8, preferably 7.2-7.6.

[0072] In another preferred embodiment, the permeabilization buffer contains 50-150 mM NaCl or other salts with equivalent conductivity.

[0073] In another preferred embodiment, the permeabilization buffer further contains a cell protein protectant, which is 1-100 mM Glycine, 0.1%-2% (v / v) BSA, or other similar substances.

[0074] In another preferred embodiment, the permeabilization buffer contains a permeabilizing agent, and the permeabilizing agent is selected from the following group: Tween20, SDS, NP40, Digtonin, CHAPS, sodium deoxycholate, or a combination thereof; preferably Tween20, SDS or NP40.

[0075] In another preferred embodiment, the permeabilization buffer comprises one or more selected from the following group:

[0076] 0.1%-0.5% (v / v), preferably 0.2% (v / v) NP40,

[0077] 0.1%-0.5% (v / v), preferably 0.1% (v / v) SDS,

[0078] 0.1%-0.5% (v / v), preferably 0.1% (v / v) Tween20,

[0079] 0.01%-0.2% (v / v), preferably 0.05% (v / v) Digitonin,

[0080] 0.1%-0.5% (v / v), preferably 0.1% (v / v) TrinonX-100,

[0081] 0.1%-0.5% (v / v), preferably 0.1% (v / v) CHAPS.

[0082] In another preferred embodiment, the concentration C2 of the permeabilizing agent is 0.005% to 5%, preferably 0.01% to 2%.

[0083] In another preferred embodiment, the cell washing buffer is a buffer containing 0.01% to 0.1% permeabilizing agent.

[0084] In another preferred embodiment, the permeabilization agent contained in the cell washing buffer is selected from the following group: Tween20, TritonX100, SDS, NP40, Digtonin, or a combination thereof.

[0085] In another preferred embodiment, the pH value of the cell washing buffer is 7.2-7.6.

[0086] In another preferred embodiment, the cell washing buffer contains 100-150 mM NaCl or other salts with equivalent conductivity.

[0087] In another preferred embodiment, the fragmentation reaction is performed by a transposase, and the transposase is selected from the group consisting of pA / G-Tn5, protein A-Tn5, protein G-Tn5, protein A-protein G-Tn5, or a combination thereof.

[0088] In another preferred embodiment, the fragmentation reaction reagents include but are not limited to transposase, magnetic beads, primary antibodies, and secondary antibodies.

[0089] In another preferred embodiment, the kit further comprises a cross-linking removal reagent, a reaction termination reagent, or a reagent for PCR amplification.

[0090] In another preferred embodiment, the cross-linking removal reagent includes: 2-10 μL 0.5 M EDTA; 1-8 μL 10% SDS; and 0.2-5 μL 20 mg / mL proteinase K.

[0091] In a third aspect of the present invention, a method for measuring protein-chromatin interactions is provided, comprising:

[0092] (S1) constructing a nucleic acid library using the method according to claim 1; and

[0093] (S2) The nucleic acid library is sequenced to generate multiple sequencing reads for measuring protein-chromatin interactions.

[0094] In another preferred embodiment, the protein includes a DNA-binding protein that has weak binding ability to DNA or has highly dynamic binding to DNA.

[0095] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features described in detail below (such as in the embodiments) can be combined with each other to form new or preferred technical solutions. Due to space limitations, they will not be listed here one by one. BRIEF DESCRIPTION OF THE DRAWINGS

[0096] FIG1 shows a schematic diagram of the formaldehyde light cross-linking process of the ChiTag of the present invention and the classic CUT&Tag / CUT&Tag.

[0097] Figure 2 shows the electrophoresis pattern of failed library construction using the classic CUT&Tag process after formaldehyde re-crosslinking.

[0098] Figure 3 shows a comparison of electrophoresis patterns of libraries constructed using the CUT&Tag and ChiTag processes after formaldehyde re-crosslinking.

[0099] Figure 4 shows the electrophoretic patterns of different antibodies constructed using the CUT&Tag (classic non-cross-linked method) and ChiTag processes.

[0100] Figure 5 shows a comparison of the signal-to-noise ratio maps (partially extracted) of different antibodies (CTCF, GR, Pol II, H3K4me2) sequenced using the CUT&Tag and ChiTag processes.

[0101] Figure 6 shows the peak number statistics of different antibodies (CTCF, GR, Pol II, H3K4me2) using the CUT&Tag and ChiTag processes to build libraries for sequencing. DETAILED DESCRIPTION

[0102] After extensive and in-depth research, the inventors unexpectedly discovered for the first time that by immobilizing cells with heavy cross-linking (for example, by 0.5% to 5% formaldehyde, cross-linking time: 5 to 60 minutes), and permeabilizing the cells, combined with CUT&Tag technology, nucleic acid libraries can be constructed efficiently and quickly after de-crosslinking. In the present invention, the non-permeabilized (or non-permeabilized) cell samples obtained after sufficient cross-linking of cells cannot obtain broken bands by the classic CUT&Tag method without cell permeabilization. The ChiTag method of the present invention has a low cell requirement (less than 100,000), a high sequencing signal-to-noise ratio, and a relatively simple operation. While taking into account the advantages of formaldehyde heavy cross-linking fixed cells in the ChIP experiment, the yield of the constructed library can be increased by 300 to 1000 times compared to the classic CUT&Tag method. In particular, the ChiTag method has significant advantages in exploring weak protein-DNA interactions. The present invention was completed on this basis.

[0103] the term

[0104] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0105] The term "about" can refer to a value or composition that is within an acceptable error range for the particular value or composition as determined by one of ordinary skill in the art, which will depend in part on how the value or composition is measured or determined.

[0106] As used herein, the terms "comprising" or "including" may be open, semi-closed, or closed. In other words, the terms also include "consisting essentially of" or "consisting of."

[0107] Methods for studying protein-DNA interactions

[0108] Currently, there are three main methods for studying protein-DNA interactions:

[0109] 1. Chromatin immunoprecipitation (ChIP): The process is as follows: cross-linking and fixing cells with 1% to 5% formaldehyde → ultrasonically disrupting chromatin → immunoprecipitation → DNA fragment library construction and sequencing. This method has disadvantages such as large material requirements (1 million to 10 million cells), long processing time (3 to 5 days), high background noise, high antibody consumption, and poor experimental reproducibility. In addition, the method is cumbersome and difficult to operate, further limiting its use.

[0110] Second, CUT&RUN, a method for targeted disruption and library construction using a target-specific primary antibody combined with protein A / protein G-micrococcal enzyme (pA / G-MNase). This method does not require formaldehyde cross-linking, is time-consuming (1-2 days), requires a low cell count (100,000), and is significantly less difficult to perform than ChIP.

[0111] 3. CUT&Tag technology: This technology uses cells or cell nuclei for experiments, without the need for cross-linking and fixing cells (or using 0.1-0.2% formaldehyde, 2-3 minutes of light cross-linking). Targeted fragmentation is achieved by binding the protein A / protein G-Tn5 transposase to the antibody. A high-salt buffer (no less than 300mM NaCl) is used to inhibit the efficiency of the transposase's cleavage, reducing the generation of random fragments caused by nonspecific binding. This method has the advantages of low cell requirement (10,000-100,000 cells), short time consumption (8-10 hours), lower background noise, and simple experiments.

[0112] As used herein, in "formaldehyde re-crosslinking", 1% to 5% formaldehyde is generally used to carry out a crosslinking reaction for 10 to 60 minutes.

[0113] As used herein, in "light formaldehyde cross-linking", 0.1% to 0.2% formaldehyde is generally used to carry out a cross-linking reaction for 2 to 3 minutes.

[0114] As used herein, "CUT&Tag light crosslinking," "CUT&Tag formaldehyde light crosslinking," or "classic CUT&Tag light crosslinking assay" are used interchangeably and generally refer to a classic CUT&T assay in which cells are treated with formaldehyde light crosslinking followed by a CUT&T assay.

[0115] In conventional formaldehyde cross-linking and fixation experiments on cells, the commonly used formaldehyde concentration is 1% to 5%, and the time is 10-30 minutes. Under these conditions, the cells are generally considered to be fully fixed, and the experimental results are generally considered to be credible. Conventional CHIP experiments are generally in this cross-linking range.

[0116] ChiTag method of the present invention

[0117] As used herein, the "ChiTag method of the present invention," the "ChiTag process of the present invention," the "method of combining formaldehyde recrosslinking and CUT&Tag of the present invention," and the "method of combining formaldehyde recrosslinking and CUT&Tag of the present invention" can be used interchangeably and all refer to the method of the first aspect of the present invention, specifically, a method of immobilizing cells by formaldehyde recrosslinking, permeabilizing the cells, and then combining CUT&Tag technology.

[0118] It should be understood that the formaldehyde re-crosslinking or cell immobilization treatment in the present invention preferably allows the cells to be fully crosslinked or fully immobilized. Preferably, 1% to 5% formaldehyde is used to re-crosslink and fix the cells so that the binding of DNA binding proteins to chromosomes is fixed. During the experiment, the DNA binding protein is linked to the DNA through a covalent bond, and the relative position is fixed, which can more realistically reflect the actual situation of the sample at a specific time. Preferably, the crosslinking agent used for the immobilization treatment of cells of the present invention adopts a 0.5% to 5% formaldehyde solution, and the crosslinking time is 5 to 60 minutes; the crosslinking agent is not limited to formaldehyde, and includes other crosslinking agents with the same fixation effect such as EGS and DSG; the crosslinking agent for cell fixation in the technical process is not limited to one, and can be two or more crosslinking agents used in combination.

[0119] Specifically, the ChiTag method of the present invention, i.e., the technical process of combining formaldehyde re-crosslinking with CUT&Tag, comprises the following steps:

[0120] Cell fixation → termination of fixation → cell permeabilization → cell washing → cell binding to magnetic beads → antibody incubation → pA / G-Tn5 incubation and fragmentation reaction → reaction termination and cross-linking reversal → DNA extraction → library preparation.

[0121] The cell density of the cross-linking reaction system in the technical process is 3×10 3 ~3×10 6 / mL, and the final concentration of fixed termination was 125-1000mM Glycine;

[0122] The buffer used for cell permeabilization in the technical process is a buffer containing 0.01% to 2% cell permeabilization agent.

[0123] The buffer is PB, Tris, HEPES, etc.; the cell membrane permeabilizer in the buffer includes but is not limited to one or a combination of two or more of Tween20, SDS, NP40, Digtonin, CHAPS, and sodium deoxycholate; the pH value of the buffer is 7.0-7.8; the buffer contains 50-150 mM NaCl, or other salts with equivalent conductivity; the buffer contains 1-100 mM Glycine, 0.1%-2% BSA, or other similar agents as cell protein protectants;

[0124] The cell density for cell permeabilization in the technical process was 3×10 3 ~3×10 6 / mL;

[0125] The cell permeabilization treatment time in the technical process is 5 to 60 minutes; the permeabilization treatment temperature is 45 to 68°C;

[0126] The cell washing buffer in the technical process is a buffer containing 0.01% to 0.1% cell membrane permeabilizing agent;

[0127] The buffer comprises PB, Tris, HEPES, etc.; the permeabilizing agent in the buffer comprises but is not limited to Tween20, TritonX100, SDS, NP40, Digtonin, one, two, or a combination of multiple; the pH value of the buffer is 7.2-7.6; the buffer contains 150 mM NaCl or other salts with equivalent conductivity;

[0128] The magnetic beads in the process are ConA magnetic beads;

[0129] The primary antibody incubation time in the technical process is 1 to 16 hours;

[0130] The transposase in the technical process is pA / G-Tn5, which can be any one of protein A-Tn5, protein G-Tn5, and protein A-protein G-Tn5;

[0131] The pA / G-Tn5 incubation interruption time in the technical process is 0.5 to 3 hours;

[0132] The decrosslinking temperature in the technical process is 50 to 60° C.; the decrosslinking time in the technical process is 0.5 to 12 hours.

[0133] The main advantages of the present invention include

[0134] 1. In experiments with formaldehyde-fixed cells, the yield of libraries constructed using the ChiTag process was increased by 300-1000 times compared to the CUT&Tag light cross-linking process.

[0135] 2. Using formaldehyde-re-crosslinked cells and the ChiTag workflow, compared to the classic CUT&Tag workflow without crosslinking, we found that sequencing of transcription factors and dynamic binding proteins using the ChiTag workflow performed better. Using the same number of cells, the same antibody library, and the same sequencing load, the ChiTag workflow produced more peaks and a higher signal-to-noise ratio than the traditional CUT&Tag workflow. Some transcription factors, which showed no peaks using the CUT&Tag workflow, showed significant enrichment signals using the ChiTag workflow.

[0136] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended to illustrate the present invention only and are not intended to limit the scope of the present invention. The experimental methods in the following examples, for which detailed conditions are not specified, were generally performed under conventional conditions such as those described in Sambrook et al., Molecular Cloning: A Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or according to the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are calculated by weight.

[0137] In this example, concanavalin A magnetic beads (ConA beads, N251), CUT&Tag kit (CUT&Tag 3.0, N259), DNA extraction magnetic beads (Tagment DNA Exract Beads, N245, NovoNGSDNA Clean Beads, N240), and secondary antibodies (Goat Anti-Rabbit IgG H&L, N269, Goat Anti-Mouse IgG H&L, N270) from Suzhou Jinan Protein Technology Co., Ltd. were used. The primary antibodies used in this example were purchased from EMD Millipore (H3K4me2, 07-030, CTCF, 07-729); Cell Signaling (Pol II, 2629S); Santa Cruz Biotechnology (GR, sc-393232), and ACTIVE MOTIF (H3K4me3, 39159). The cells used in the present invention are human K562 cells.

[0138] Table 1. Primer sequences

[0139] The classic CUT&Tag experimental process, the classic CUT&Tag light cross-linking experimental process, and the ChiTag experimental process for heavily cross-linked fixed cells are shown in Figure 1.

[0140] The S1 classic CUT&Tag process is as follows (using the CUT&Tag kit, see Figure 1A for the experimental process):

[0141] 1. Cell Preparation

[0142] 1) Collect and count fresh cells at room temperature. Place the desired cells into a new 1.5 mL centrifuge tube and centrifuge at 600 g for 5 minutes at room temperature. Carefully aspirate the supernatant.

[0143] 2) Add 1 mL of Wash Buffer to the cell pellet from the previous step, mix gently by pipetting, and centrifuge at 600 g for 5 minutes at room temperature. Discard the supernatant.

[0144] 3) Add 90 μL Wash Buffer to the cell pellet from the previous step and resuspend the cells.

[0145] 2.ConA magnetic beads bind to cells

[0146] Add 10 μL of pretreated ConA magnetic beads to the 90 μL sample from the previous step, mix gently by pipetting, and place on a rotating mixer at room temperature for 10 minutes.

[0147] 3.ConA magnetic beads-cells bind to primary antibodies

[0148] 1) Dilute the primary antibody with Primary Antibody Buffer. Each experimental sample requires 50 μL of primary antibody dilution buffer. The primary antibody dilution ratio is based on the instructions. Place the prepared primary antibody dilution buffer on ice until ready for use.

[0149] 2) Place the centrifuge tube containing ConA magnetic beads and cells that have been bound in step 2 on a magnetic rack and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant, remove the centrifuge tube, add 50 μL of primary antibody diluent, and incubate at room temperature for 2 hours or at 4°C overnight.

[0150] 4.ConA magnetic beads-cells and secondary antibody binding and washing

[0151] 1) Remove the centrifuge tube after primary antibody incubation and place it on a magnetic stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0152] 2) Remove the centrifuge tube from the magnetic stand, add 100 μL of secondary antibody diluent, resuspend the ConA magnetic beads-cells, gently pipette to mix, and incubate at room temperature for 1 hour;

[0153] 3) After the secondary antibody incubation is complete, place the centrifuge tube on a magnetic stand for 2 minutes and carefully remove the supernatant.

[0154] 4) Remove the centrifuge tube from the magnetic stand, add 200 μL Antibody Buffer, resuspend the ConA magnetic beads-cells, gently pipette to mix, and let stand at room temperature for 3 minutes;

[0155] 5) Repeat steps 4-3) and 4) once.

[0156] 5. Transposome Binding and Washing

[0157] 1) Place the sample after the previous step on a magnetic stand and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0158] 2) Remove the centrifuge tube from the magnetic stand, add 90 μL of ChiTag transposome diluent, gently pipette to resuspend the cells, and incubate the mixed sample at room temperature for 1 hour.

[0159] 3) Place the centrifuge tube containing the transposon on a magnetic stand and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0160] 4) Remove the centrifuge tubes from the magnetic stand and add 200 μL ChiTag Buffer to each tube of sample. Mix gently by pipetting to resuspend all ConA magnetic beads and cells. Let stand at room temperature for 3 minutes.

[0161] 5) Repeat steps 5-3) and 4) once.

[0162] 6. Fragmentation reaction

[0163] 1) Place the sample after the previous step on a magnetic stand and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully remove the supernatant;

[0164] 2) Remove the centrifuge tube from the magnetic rack, add 40 μL Tagmentation Buffer, gently pipette to mix the cells, and place in an incubator at 37°C for 1 hour. Remove the 5× Stop Buffer and thaw at room temperature for later use.

[0165] 3) Vortex mix the 5× Stop Buffer. Add 10 μL of 5× Stop Buffer to the incubated sample, pipette or vortex mix thoroughly, and incubate in a metal bath or water bath at 55°C for 10 min to terminate the fragmentation reaction.

[0166] The S2 classic CUT&Tag light cross-linking process is as follows (using the CUT&Tag kit, the experimental process is shown in Figure 1B):

[0167] 1. Cell Preparation

[0168] 1) Collect and count the cells. Place the desired cells into a new 1.5 mL centrifuge tube and centrifuge at 600 g for 5 minutes. Carefully aspirate the supernatant.

[0169] 2) Add 1 mL of PBS to the cell pellet from the previous step to resuspend the cells, centrifuge at 600 g for 5 minutes at room temperature, and discard the supernatant.

[0170] 2. Formaldehyde cross-linking and termination

[0171] 1) Prepare formaldehyde solution (formaldehyde-PBS) with a final concentration of 0.1% in advance;

[0172] 2) 3×10 6 Formaldehyde cross-linking was performed at a cell density of 100 cells / mL and the reaction was carried out at room temperature for 2 minutes;

[0173] 3) Add 2.5 M glycine to a final concentration of 125 mM and neutralize at room temperature for 5 minutes;

[0174] 4) Centrifuge at 600g for 5 minutes and resuspend the cells in 90 μL Wash Buffer.

[0175] 3.ConA magnetic beads bind to cells

[0176] Add 10 μL of pretreated ConA magnetic beads to the 90 μL sample from the previous step, mix gently by pipetting, and place on a rotating mixer at room temperature for 10 minutes.

[0177] 4.ConA magnetic beads-cells and primary antibody binding

[0178] 1) Dilute the primary antibody with Primary Antibody Buffer. Each experimental sample requires 50 μL of primary antibody dilution buffer. The primary antibody dilution ratio is based on the instructions. Place the prepared primary antibody dilution buffer on ice until ready for use.

[0179] 2) Place the centrifuge tube containing ConA magnetic beads and cells that have been bound in step 2 on a magnetic rack and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant, remove the centrifuge tube, add 50 μL of primary antibody diluent, and incubate at room temperature for 2 hours or at 4°C overnight.

[0180] 5.ConA magnetic beads-cells and secondary antibody binding and washing

[0181] 1) Remove the centrifuge tube after primary antibody incubation and place it on a magnetic stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0182] 2) Remove the centrifuge tube from the magnetic stand, add 100 μL of secondary antibody diluent, resuspend the ConA magnetic beads-cells, gently pipette to mix, and incubate at room temperature for 1 hour;

[0183] 3) After the secondary antibody incubation is complete, place the centrifuge tube on a magnetic stand for 2 minutes and carefully remove the supernatant.

[0184] 4) Remove the centrifuge tube from the magnetic stand, add 200 μL Antibody Buffer, resuspend the ConA magnetic beads-cells, gently pipette to mix, and let stand at room temperature for 3 minutes;

[0185] 5) Repeat steps 4-3) and 4) once.

[0186] 6. Transposome Binding and Washing

[0187] 1) Place the sample after the previous step on a magnetic stand and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0188] 2) Remove the centrifuge tube from the magnetic stand, add 90 μL of ChiTag transposome diluent, gently pipette to resuspend the cells, and incubate the mixed sample at room temperature for 1 hour.

[0189] 3) Place the centrifuge tube containing the transposon on a magnetic stand and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0190] 4) Remove the centrifuge tubes from the magnetic stand and add 200 μL ChiTag Buffer to each tube of sample. Mix gently by pipetting to resuspend all ConA magnetic beads and cells. Let stand at room temperature for 3 minutes.

[0191] 5) Repeat steps 5-3) and 4) once.

[0192] 7. Fragmentation reaction

[0193] 1) Place the sample after the previous step on a magnetic stand and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully remove the supernatant;

[0194] 2) Remove the centrifuge tube from the magnetic rack, add 40 μL Tagmentation Buffer, gently pipette to mix the cells, and place in an incubator at 37°C for 1 hour. Remove the 5× Stop Buffer and thaw at room temperature for later use.

[0195] 3) Vortex mix the 5× Stop Buffer. Add 10 μL of 5× Stop Buffer to the incubated sample, pipette or vortex mix thoroughly, and incubate in a metal bath or water bath at 55°C for 10 min to terminate the fragmentation reaction.

[0196] The S3 ChiTag experimental process is as follows (using the CUT&Tag kit, the experimental process is shown in Figure 1, Panel C):

[0197] 1. Cell Preparation

[0198] 1) Collect and count fresh cells at room temperature. Place the required amount of cells into a new 1.5 mL centrifuge tube and centrifuge at 600 g for 5 minutes at room temperature. Discard the supernatant.

[0199] 2) Add 1 mL of PBS and mix gently by pipetting. Centrifuge at 600 g for 5 min at room temperature and discard the supernatant.

[0200] 2. Formaldehyde cross-linking

[0201] 1) Prepare formaldehyde solution (formaldehyde-PBS) with a final concentration of 1% in advance;

[0202] 2) According to 3×10 6Add the corresponding volume of 1% formaldehyde-PBS solution to the cell pellet in step 1-2) at a cell density of 10 cells / mL and incubate at room temperature for 10 minutes.

[0203] 3. Termination of cross-linking

[0204] 1) Add 2.5 M glycine stock solution to the formaldehyde cross-linking system to make the final glycine concentration in the reaction system 125 mM and let it stand at room temperature for 5 minutes;

[0205] 2) Centrifuge at 1300 g for 5 min at room temperature and discard the supernatant;

[0206] 3) Add 1 mL of PBS to the cell pellet to resuspend the cells, centrifuge at 1300 g for 5 minutes at room temperature, and discard the supernatant;

[0207] 4) Repeat steps 3-3) once.

[0208] 4. Cell Permeabilization

[0209] To the precipitate in step 3-4), 200 μL of permeabilization buffer (PBS, 0.2% NP40, 0.1% SDS, 0.1% Tween 20, 0.05% Digitonin, 0.1% Trinon X-100, 0.1% CHAPS, 50 mM Glycine) was added and incubated in a 58°C metal bath for 10 min.

[0210] 5. Washing

[0211] 1) Add 800 μL of Wash Buffer (PBS, pH 7.4, 0.5 mM Spermidine, 0.15% Tween 20, 0.15% NP40, 0.01% Digitonin, 0.1% Triton X-100) to the EP tube from the previous step. Mix gently by pipetting. Incubate at 37°C for 30 min, then centrifuge at 600 g for 5 min at room temperature. Discard the supernatant.

[0212] 2) Add 90 μL Wash Buffer to the pellet from the previous step and resuspend the cells.

[0213] 6.ConA magnetic beads bind to cells

[0214] Add 10 μL of pretreated ConA magnetic beads to 90 μL of sample, mix gently by pipetting, and incubate on a rotating mixer at room temperature for 10 min.

[0215] 7.ConA-cells bind to primary antibody

[0216] 1) Dilute the primary antibody with Primary Antibody Buffer. Each experimental sample requires 50 μL of primary antibody dilution buffer. The primary antibody dilution ratio is based on the instructions. Place the prepared primary antibody dilution buffer on ice until ready for use.

[0217] 2) Place the ConA magnetic beads-cells incubated in step 1 on a magnetic rack and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant, remove the EP tube from the magnetic rack, add 50 μL of pre-chilled primary antibody dilution, pipette to mix, and incubate at room temperature for 2 hours or at 4°C overnight.

[0218] 8.ConA-cells bind to secondary antibodies and wash

[0219] 1) Remove the EP tube after primary antibody incubation and place it on a magnetic stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0220] 2) Remove the EP tube from the magnetic stand, add 100 μL of secondary antibody diluent, resuspend the ConA magnetic beads-cells, gently pipette to mix, and incubate at room temperature for 1 hour;

[0221] 3) Place the EP tube incubated with secondary antibody on a magnetic stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0222] 4) Remove the EP tube from the magnetic stand, add 200 μL Antibody Buffer, resuspend the ConA magnetic beads-cells, gently pipette to mix, and let stand at room temperature for 3 minutes;

[0223] 5) Repeat steps 3) and 4) once.

[0224] 9.ConA- cells are incubated with pA / G-Tn5-MgCl2

[0225] 1) Place the sample from the previous step on a magnetic stand and let it stand for 2 minutes. After the magnetic beads are completely separated from the liquid, carefully aspirate the supernatant.

[0226] 2) Remove the EP tubes from the magnetic stand and add 40 μL of transposome dilution buffer and 0.8 μL of 0.5 M MgCl2 to each tube. Mix thoroughly by gently pipetting. Incubate in a 37°C incubator for 1 hour.

[0227] 10. Termination and de-crosslinking

[0228] 1) Add 5 μL 0.5 M EDTA, 4 μL 10% SDS, and 1 μL 20 mg / mL Proteinase K to each tube of sample incubated in the previous step;

[0229] 2) Transfer the sample to a PCR tube and incubate in a PCR instrument at 55°C for 2.5 hours.

[0230] S4. Magnetic bead method to recover CUT&Tag / ChiTag reaction termination products

[0231] 1. DNA Extraction

[0232] 1) Remove the terminated reaction product from the PCR instrument and gently pipette it evenly;

[0233] 2) Vortex and mix the Tagment DNA Exract Beads that have been equilibrated at room temperature for 10 minutes. Add twice the volume of magnetic beads to the terminated reaction product, gently pipette to mix, and let it stand at room temperature for 5 minutes.

[0234] 3) Transfer the PCR tube to a magnetic stand and let it stand for 5 minutes to allow the magnetic beads to separate from the liquid. Carefully aspirate the supernatant.

[0235] 4) Add 200 μL of freshly prepared 80% ethanol to the PCR tube. Let it stand at room temperature for 1 minute, then carefully aspirate the supernatant. Keep the PCR tube on the magnetic rack during this step.

[0236] 5) Repeat step 4) once;

[0237] 6) Place the PCR tube on a magnetic rack, open the PCR tube cap, and air-dry at room temperature (about 4 minutes) to allow the ethanol to evaporate completely.

[0238] 7) Remove the PCR tubes from the magnetic rack, add 37 μL of TE Buffer to each tube, mix thoroughly by pipetting, and let stand at room temperature for 3 minutes;

[0239] 8) Place the PCR tube on a magnetic rack and let it stand for 2 minutes to completely separate the magnetic beads from the liquid. Carefully pipette 35 μL of the supernatant into a new sterile PCR tube. The sample can be stored at -20°C or proceed directly to the next PCR amplification step.

[0240] 2. PCR Amplification

[0241] 1) Preparation of PCR amplification system:

[0242] 2) Vortex to mix, centrifuge quickly, and place in PCR instrument to start the cycle:

[0243] 3. PCR Product Purification

[0244] 1) Take the NovoNGS DNA Clean Beads out of the 4°C refrigerator in advance, vortex and mix thoroughly, and equilibrate at room temperature for 15 minutes.

[0245] 2) Vortex and mix the magnetic beads. Add 1.3 times the volume of the magnetic beads to the PCR product, pipette to mix, and let it stand at room temperature for 5 minutes.

[0246] 3) After centrifuging the PCR tube, place it on a magnetic rack and let it stand for 5 minutes to completely separate the magnetic beads from the liquid. Carefully aspirate the supernatant.

[0247] 4) Add 200 μL of freshly prepared 80% ethanol to wash the beads. Let stand at room temperature for 1 minute, then carefully aspirate the supernatant. Keep the PCR tube on the magnetic rack during this step.

[0248] 5) Repeat step 4) once;

[0249] 6) Place the PCR tube on a magnetic rack, open the PCR tube cap, and air-dry at room temperature (about 4 minutes) to allow the ethanol to evaporate completely.

[0250] 7) Remove the PCR tubes from the magnetic rack, add 20 μL of TE Buffer to each tube, mix thoroughly by pipetting, and let stand at room temperature for 3 minutes;

[0251] 8) Place the PCR tube on a magnetic rack and let it stand for 2 minutes to completely separate the magnetic beads from the liquid. Carefully pipette 20 μL of the supernatant into a new sterile PCR tube. The sample can be stored at -20°C.

[0252] Example 1: CUT&Tag experiment using the classic CUT&T process to test uncrosslinked, lightly crosslinked with formaldehyde, and heavily crosslinked cells

[0253] 1. Cell Preparation

[0254] Table 2. Experimental group design 1

[0255] 1) Take 1.8 million K562 cells and divide them into 18 aliquots in 1.5 ml EP tubes, with 100,000 cells per sample. Centrifuge at 600g for 5 minutes at room temperature and carefully remove the supernatant.

[0256] 2) Add 1 mL of Wash Buffer to the cell pellets of groups 1 / 4 / 7 from the previous step, and add 1 mL of PBS to the cell pellets of groups 2 / 5 / 8 and 3 / 6 / 9. Mix gently by pipetting, then centrifuge at 600 g for 5 minutes at room temperature. Discard the supernatant, place the cells of groups 1 / 4 / 7 on ice, and proceed to the CUT&Tag assay after the cells of groups 2 / 5 / 8 and 3 / 6 / 9 have been processed.

[0257] 3) Add 200 μL of the pre-prepared 0.1% formaldehyde-PBS solution to the cell pellets of groups 2 / 5 / 8 and react at room temperature for 2 min; add 200 μL of the pre-prepared 1% formaldehyde-PBS solution to the cell pellets of groups 3 / 6 / 9 and react at room temperature for 10 min;

[0258] 4) After the cross-linking reaction, 10.5 μL of 2.5 M glycine was added to the cells in groups 2 / 5 / 8, and 12.1 μL of 2.5 M glycine was added to the cells in groups 3 / 6 / 9. The reaction was incubated at room temperature for 5 minutes to terminate the cross-linking reaction.

[0259] 5) Centrifuge at 1300 g for 5 min, discard the supernatant, add 1 mL of Wash Buffer to each of the cell pellets in groups 2 / 5 / 8 and 3 / 6 / 9, mix gently by pipetting, and centrifuge at 1300 g for 5 min, discard the supernatant;

[0260] 6) Repeat steps 1-5) once;

[0261] 7) Add 90 μL Wash Buffer to each sample to resuspend the cells.

[0262] Perform the following steps in the same way as in the classic CUT&Tag process in S1:

[0263] 2.ConA magnetic beads bind to cells

[0264] 3.ConA magnetic beads-cells bind to primary antibodies

[0265] 4.ConA magnetic beads bind to cells

[0266] 5.ConA magnetic beads-cells bind to primary antibodies

[0267] 6.ConA magnetic beads-cells and secondary antibody binding and washing

[0268] Recover the CUT&Tag reaction termination products using the magnetic bead method in S4

[0269] Sets 1 / 2 / 3 / 4 / 5 / 6 are set to 17 cycles, and sets 7 / 8 / 9 are set to 15 cycles.

[0270] The PCR amplification products were observed by agarose gel electrophoresis, and the results are shown in Figure 2.

[0271] As shown in Figure 2, the classic CUT&Tag process can obtain specific interruption bands for antibodies Pol II, CTCF, and H3K4me3, confirming that these antibodies have not failed. By comparison, the classic CUT&Tag process can still obtain interruption bands after formaldehyde light cross-linking, but the CUT&Tag process cannot obtain interruption bands for cells that have undergone formaldehyde heavy cross-linking. Therefore, the classic CUT&Tag process is only suitable for formaldehyde light cross-linking, but not for formaldehyde heavy cross-linking.

[0272] Example 2. Cells were recrosslinked with formaldehyde and then subjected to the classic CUT&Tag and ChiTag protocols.

[0273] Table 3. Experimental group design 2

[0274] 1. Cell Preparation:

[0275] 1) Place 1.2 million K562 cells (100,000 / group) in a new 1.5 mL centrifuge tube and centrifuge at 600 g for 5 minutes at room temperature. Carefully aspirate the supernatant.

[0276] 2) Add 1 mL of PBS to the cell pellet from the previous step, mix gently by pipetting, centrifuge at 600 g for 5 minutes at room temperature, and discard the supernatant.

[0277] 2. Formaldehyde cross-linking

[0278] 1) Prepare formaldehyde solution (formaldehyde-PBS) with a final concentration of 1% in advance;

[0279] 3) Add 400 μL of the pre-prepared 1% formaldehyde-PBS solution to the cell pellet from the previous step and react at room temperature for 10 minutes.

[0280] 3. Termination of cross-linking

[0281] 1) Add 25 μL of 2.5 M glycine to the reaction system in the previous step and incubate at room temperature for 5 min to terminate the cross-linking reaction. During this time, divide the cells into 12 groups (1-1 / 1-2 / 2-1 / 2-1 / 3-1 / 3-2 / 4-1 / 4-2 / 5-1 / 5-2 / 6-1 / 6-2) with 35 μL / group;

[0282] 2) Centrifuge at room temperature for 5 minutes and discard the supernatant;

[0283] 3) Add 1 mL of Wash Buffer to each cell pellet, wash the cells, centrifuge at room temperature for 5 minutes, and discard the supernatant;

[0284] 4) Repeat steps 3-3) once;

[0285] 5) Resuspend the cell pellets in groups 1, 2, and 3 with 90 μL Wash Buffer and proceed to the CUT&Tag process. Resuspend the cell pellets in groups 4, 5, and 6 with 90 μL Wash Buffer and proceed to the ChiTag process.

[0286] CUT&Tag process (1 / 2 / 3 groups of cells):

[0287] Perform the following steps in the same way as in the classic CUT&Tag process in S1:

[0288] 4.ConA magnetic beads bind to cells

[0289] 5.ConA magnetic beads-cells bind to primary antibodies

[0290] 6.ConA magnetic beads-cells and secondary antibody binding and washing

[0291] 7. Transposome Binding and Washing

[0292] 8. Fragmentation reaction

[0293] ChiTag workflow (4 / 5 / 6 cell groups):

[0294] Follow the same steps as in the ChiTag experiment workflow in S3:

[0295] 4. Cell Permeabilization

[0296] 5. Washing

[0297] 6.ConA magnetic beads bind to cells

[0298] 7.ConA-cells bind to primary antibody

[0299] 8.ConA-cells bind to secondary antibodies and wash

[0300] 9.ConA- cells are incubated with pA / G-Tn5-MgCl2

[0301] 10. Termination and de-crosslinking

[0302] The CUT&Tag / ChiTag reaction termination products were recovered using the magnetic bead method.

[0303] Sets 1 / 3 / 4 / 6 are set to 19 cycles, and sets 2 / 5 are set to 18 cycles.

[0304] The PCR amplification products were observed by agarose gel electrophoresis, and the results are shown in Figure 3.

[0305] As shown in Figure 3, after K562 cells were re-crosslinked with formaldehyde, no interrupted bands were obtained when the antibody Pol II / H3K4me2 / CTCF was detected using the classic CUT&Tag process, while obvious interrupted bands were obtained using the ChiTag process of the present invention.

[0306] The library was quantitatively analyzed by qPCR, and the results are shown in Table 4. Combining Figure 3 and Table 4, it can be seen that after the cells were re-crosslinked with formaldehyde, the yield of the library constructed using the ChiTag process can be increased by 300 to 1000 times compared with the CUT&Tag process.

[0307] Table 4. Library concentrations obtained using different workflows for different antibodies

[0308] Example 3 Detection of different antibodies using classic CUT&Tag and ChiTag processes on K562 cells

[0309] Table 5. Experimental group design three

[0310] 1. Cell Preparation:

[0311] 1.6 million K562 cells (100,000 cells / sample) were placed in a new 1.5 mL centrifuge tube, divided equally into groups A and B, and centrifuged at 600 g for 5 min. The supernatant was carefully aspirated. 1 mL of PBS was added to the cells in group A, and 1 mL of Wash Buffer was added to the cells in group B. The cells were divided equally into eight groups (5, 6, 7, and 8), mixed thoroughly by pipetting, and centrifuged at 600 g for 5 min. After discarding the supernatant, the cells in group A entered the ChiTag process, and the cells in group B were added with 90 μL of Wash Buffer to each group and entered the CUT&Tag process.

[0312] ChiTag workflow (1 / 2 / 3 / 4 groups of cells):

[0313] Follow the same steps as in the ChiTag experiment workflow in S3:

[0314] 2. Formaldehyde cross-linking

[0315] 3. Termination of cross-linking

[0316] 4. Cell Permeabilization

[0317] 5. Washing

[0318] 6.ConA magnetic beads bind to cells

[0319] 7.ConA-cells bind to primary antibody

[0320] 8.ConA-cells bind to secondary antibodies and wash

[0321] 9.ConA- cells are incubated with pA / G-Tn5-MgCl2

[0322] 10. Termination and de-crosslinking

[0323] CUT&Tag process (5 / 6 / 7 / 8 groups of cells)

[0324] Perform the following steps in the same way as in the classic CUT&Tag process in S1:

[0325] 2.ConA magnetic beads bind to cells

[0326] 3.ConA magnetic beads-cells bind to primary antibodies

[0327] 4.ConA magnetic beads-cells and secondary antibody binding and washing

[0328] 5. Transposome Binding and Washing

[0329] 6. Fragmentation reaction

[0330] The CUT&Tag / ChiTag reaction termination products were recovered using the magnetic bead method.

[0331] Group 1 / 5 was set for 16 cycles, Groups 2 / 3 / 6 / 7 were set for 18 cycles, and Group 4 / 8 was set for 22 cycles. PCR amplification products were detected by agarose gel electrophoresis, and the results are shown in Figure 4.

[0332] As shown in Figure 4, among the antibodies tested in this example, H3K4me2, Pol II, and CTCF can be fragmented using both the classic uncross-linked CUT&Tag process and the ChiTag process suitable for cross-linked cells. However, the antibody GR can only be fragmented using the ChiTag process. This result indicates that for some proteins that bind weakly to DNA, the ChiTag process can achieve better fragmentation effects.

[0333] The PCR products were purified and sent to Novogene for sequencing. The sequencing results were analyzed on the Galaxy website (https: / / usegalaxy.org / ), and the sequencing maps were viewed using IGV software. The sequencing results are shown in Figures 5, 6, and Table 6.

[0334] Figure 5 shows the signal-to-noise ratio graphs (partially extracted) of different antibodies (CTCF, GR, Pol II, H3K4me2) using the CUT&Tag and ChiTag processes to construct libraries for sequencing.

[0335] Figure 5 shows that within a given region, ChiTag introduces formaldehyde crosslinking, but its signal-to-noise ratio does not significantly decrease compared to the classic CUT&Tag. For the GR antibody, the fragmentation bars obtained using the CUT&Tag process are all background, while the ChiTag process can generate peaks with clear read accumulation signals.

[0336] Table 6. Comparison of sequencing data using CUT&Tag and ChiTag pipelines for different antibodies

[0337] Combining Table 6 and Figure 6, it can be seen that the CUT&Tag process has a clear advantage only in the detection of histone modifications. The H3K4me2 antibody obtained more peaks using the CUT&Tag process than the ChiTag process, while the antibodies Pol II, CTCF, and GR obtained more peaks using the ChiTag process, indicating that the signal-to-noise ratio of the ChiTag process tends to improve for non-histone modified targets, especially GR.

[0338] Based on the above results, the ChiTag process has significant advantages in exploring protein-DNA interactions, especially weak protein-DNA interactions.

[0339] discuss:

[0340] Those skilled in the art are aware that CUT&Tag technology has limitations in many practical applications. For example, some transcription factors produce excellent results using ChIP-Seq, but struggle to do so using CUT&Tag. For some transcription factors, while results can be obtained, the binding site signal intensity is weak and the background is high. Furthermore, CUT&Tag technology performs experiments in cells or nuclei. However, cells are complex, containing numerous proteins and other substances. Without crosslinking, other biochemical reactions may occur during the 8-10 hour experiment that could affect the results. Short-term light crosslinking with 0.1% to 0.2% formaldehyde may not be equivalent to longer, heavier crosslinking (1% to 5% formaldehyde, 10-60 minutes) for cell fixation. Therefore, for assays of DNA-binding proteins whose binding to DNA is dynamic, results obtained without crosslinking or with light crosslinking (0.1% to 0.2% formaldehyde) may not reflect the objective conditions of the experimental sample.

[0341] In summary, CUT&Tag technology faces significant challenges. A key step in ChIP-Seq is the use of 1% to 5% formaldehyde cross-linking to fix the binding of DNA-binding proteins to chromosomes, thereby maintaining their in situ state throughout the experiment and accurately reflecting the objective state of the sample at a specific time point. This is of great significance in genetic development research.

[0342] Faced with the shortcomings of CUT&Tag technology, researchers in this field have been forced to use the traditional and cumbersome ChIP technology. Therefore, how to overcome the technical difficulties of CUT&Tag and make it applicable to the exploration of most protein-DNA interactions while maintaining the simplicity and rapidity of CUT&Tag technology is an urgent problem to be solved in the field of epigenetic research.

[0343] The cells used in the classic CUT&Tag experiment do not require formaldehyde cross-linking or only use 0.1% to 0.2% formaldehyde for light cross-linking for 2 to 3 minutes. During the experiment, the target protein is at risk of undergoing other biochemical reactions in the complex environment of uncross-linked cells. For some DNA-binding proteins with weak binding or highly dynamic binding to DNA, the use of 0.1% to 0.2% formaldehyde light cross-linking is insufficient for protein-DNA fixation. If only the formaldehyde concentration is increased (for example, to 0.5% to 3%) and the cross-linking time is extended (5 to 60 minutes) in the CUT&Tag formaldehyde light cross-linking process, it is easy to cause library construction failure or extremely low library yield, which cannot meet the requirements of the machine, and seriously reduces the sensitivity of the CUT&Tag technology.

[0344] The inventors unexpectedly discovered that by using formaldehyde to immobilize cells and then permeabilize them, combined with CUT&Tag technology (the ChiTag process of the present invention), CUT&Tag technology can achieve the advantages of formaldehyde-re-crosslinked and fixed cells in ChIP experiments while maintaining low cell requirements, high sequencing signal-to-noise ratio, and relatively simple operation. It can also greatly increase the yield of the constructed library, thereby expanding the scope of application of this technology.

[0345] In addition, after formaldehyde cross-linking and fixation, the permeability of cells is reduced. Using traditional methods can easily lead to insufficient cell permeability. In the present invention, formaldehyde cross-linking and fixation are first performed, and then permeability treatment is performed, so that subsequent antibodies, enzymes, etc. can more easily enter the cells, the antibody binding efficiency is higher, and the enzyme fragmentation effect is more sufficient. This can further reduce the demand for cells and meet the needs of small-scale cell experiments. After the reaction, the cross-linking is removed, and the library is constructed after purification and amplification, which makes it easy to obtain more peak numbers and a higher signal-to-noise ratio.

[0346] All documents mentioned in this application are incorporated herein by reference, just as if each document were incorporated herein by reference individually. It should also be understood that after reading the above teachings of the present invention, those skilled in the art may make various changes or modifications to the present invention, and that such equivalents also fall within the scope of the claims appended hereto.

Claims

1. A method for constructing a nucleic acid library, It is characterized in that include: (S1) providing a cell sample; (S2) fixing the cell sample for t1 time (min) using a cross-linking agent solution with a final concentration of C1 (v / v), wherein the fixing treatment integral I1=C1*t1, I1≥2.5, to obtain a non-permeabilized cell sample; (S3) permeabilizing the non-permeabilized cell sample to obtain a permeabilized cell sample; (S4) washing the permeabilized cell sample to obtain a washed cell mixture; (S5) mixing the cell mixture with the pre-treated magnetic beads to obtain a cell-magnetic bead complex; (S6) treating the cell-magnetic bead conjugate with a primary antibody to obtain a primary antibody-cell-magnetic bead complex; (S7) treating the primary antibody-cell-magnetic bead complex with a secondary antibody to obtain a secondary antibody-primary antibody-cell-magnetic bead complex; (S8) treating the secondary antibody-primary antibody-cell-magnetic bead complex with a transposase to perform a fragmentation reaction to form DNA fragments; (S9) terminating the reaction and decrosslinking to obtain a reaction-terminated product; and (S10) separating, purifying and amplifying the DNA fragments in the above reaction termination products to prepare a nucleic acid library.

2. The method according to claim 1, It is characterized in that In (S2), t1 is 5 to 60 min, preferably 10 to 20 min.

3. The method according to claim 1, It is characterized in that In (S2), the permeabilizing agent is selected from one or more of the following groups: Tween20, SDS, NP40 (or IGEPAL CA-630), Digtonin, CHAPS, sodium deoxycholate, or a combination thereof; preferably Tween20, SDS or NP40 (or IGEPAL CA-630).

4. The method according to claim 1, It is characterized in that In (S3), the permeabilization treatment includes: permeabilizing the above-mentioned fixed cell sample for t2 time (min) using a permeabilization buffer containing a C2 (v / v) permeabilization agent to obtain a permeabilized cell sample.

5. A kit for constructing a nucleic acid library using CUT&Tag technology, It is characterized in that include: (1) cross-linking agent solution; (2) Permeabilization buffer; (3) Cell washing buffer; (4) fragmentation reaction reagents; and (5) Cross-linking reagent.

6. The kit according to claim 5, It is characterized in that The permeation buffer further contains a cell protein protectant, which is 1-100 mM Glycine, 0.1%-2% (v / v) BSA, or other analogs.

7. The kit according to claim 5, It is characterized in that The permeabilization buffer contains a permeabilization agent, and the permeabilization agent is selected from the following group: Tween20, SDS, NP40, Digtonin, CHAPS, sodium deoxycholate, or a combination thereof; preferably Tween20, SDS or NP40.

8. The kit according to claim 5, It is characterized in that The concentration C2 of the permeabilizing agent is 0.005% to 5%, preferably 0.01% to 2%.

9. A method for measuring protein-chromatin interactions, It is characterized in that include: (S1) constructing a nucleic acid library using the method according to claim 1; and (S2) Sequencing the nucleic acid library to generate multiple sequencing reads for measuring protein-chromatin interactions.

10. The method according to claim 9, It is characterized in that The proteins include DNA binding proteins that bind DNA weakly or have highly dynamic binding to DNA.

Citation Information

Patent Citations

  • Kit and method for identifying transcription factor and chromatin interaction in plant by using CUTTag technology

    CN114544925A

  • Lysate for animal tissue and use method thereof in CUT&Tag

    CN115141876A

  • DNA apparent modification library building method, sequencing method and library building kit thereof

    CN115386966A

  • Chromatin and / or chromosome conformation capturing method and reagent used by same

    CN116004768A

  • Application of formaldehyde recrosslinking in CUTTag technology library building

    CN117051078A